Krystal Biotech Inc
NASDAQ:KRYS

Watchlist Manager
Krystal Biotech Inc Logo
Krystal Biotech Inc
NASDAQ:KRYS
Watchlist
Price: 164.83 USD 2.49% Market Closed
Market Cap: 4.7B USD
Have any thoughts about
Krystal Biotech Inc?
Write Note

Wall Street
Price Targets

KRYS Price Targets Summary
Krystal Biotech Inc

Wall Street analysts forecast KRYS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KRYS is 211.93 USD with a low forecast of 196.95 USD and a high forecast of 232.05 USD.

Lowest
Price Target
196.95 USD
19% Upside
Average
Price Target
211.93 USD
29% Upside
Highest
Price Target
232.05 USD
41% Upside

KRYS Last Price Targets
Krystal Biotech Inc

The latest public price target was made on Sep 11, 2024 by Dae Gon Ha from Stifel Nicolaus , who expects KRYS stock to rise by 33% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Dae Gon Ha
Stifel Nicolaus
220 USD
Upside 33%
3 months ago
Sep 11, 2024
Krystal Biotech price target raised to $220 from $204 at Stifel
TheFly
Alec Stranahan
Bank of America Securities
205 USD
Upside 24%
3 months ago
Sep 2, 2024
Krystal Biotech price target raised to $205 from $195 at BofA
TheFly
Gavin Clark-Gartner
Evercore ISI
206 USD
Upside 25%
4 months ago
Aug 12, 2024
Krystal Biotech price target raised to $206 from $201 at Evercore ISI
TheFly
Dae Gon Ha
Stifel Nicolaus
204 USD
Upside 24%
8 months ago
Apr 15, 2024
Krystal Biotech (KRYS) PT Raised to $204 at Stifel
StreetInsider
Dae Gon Ha
Stifel Nicolaus
Price Target 220 USD
Upside/Downside 33%
View Source
Alec Stranahan
Bank of America Securities
Price Target 205 USD
Upside/Downside 24%
View Source
Gavin Clark-Gartner
Evercore ISI
Price Target 206 USD
Upside/Downside 25%
View Source
Dae Gon Ha
Stifel Nicolaus
Price Target 204 USD
Upside/Downside 24%
View Source
Krystal Biotech Inc Competitors:
Price Targets
MRNA
Moderna Inc
98% Upside
1167
Jacobio Pharmaceuticals Group Co Ltd
204% Upside
688373
Shanghai MicuRx Pharmaceutical Co Ltd
26% Upside
RPTX
Repare Therapeutics Inc
866% Upside
NANO
Nanobiotix SA
302% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
20% Upside
IONS
Ionis Pharmaceuticals Inc
75% Upside
ORGO
Organogenesis Holdings Inc
57% Upside

Revenue
Forecast

Revenue Estimate
Krystal Biotech Inc

The compound annual growth rate of Krystal Biotech Inc's revenue for the next 4 years is 105%.

N/A
Past Growth
105%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Krystal Biotech Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Krystal Biotech Inc

The compound annual growth rate of Krystal Biotech Inc's net income for the next 4 years is 118%.

N/A
Past Growth
118%
Estimated Growth
Estimates Accuracy
-43%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KRYS's stock price target?
Price Target
211.93 USD

According to Wall Street analysts, the average 1-year price target for KRYS is 211.93 USD with a low forecast of 196.95 USD and a high forecast of 232.05 USD.

What is Krystal Biotech Inc's Revenue forecast?
Projected CAGR
105%

The compound annual growth rate of Krystal Biotech Inc's revenue for the next 4 years is 105%.

What is Krystal Biotech Inc's Net Income forecast?
Projected CAGR
118%

The compound annual growth rate of Krystal Biotech Inc's net income for the next 4 years is 118%.

Back to Top